Unlock Premium for Just $9.99/Month – Special Launch Offer, Limited Time Only Get Premium

EVH Evolent Health Inc

Price (delayed)

$10.78

Market cap

$1.26B

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$0.81

Enterprise value

$1.87B

Evolent Health delivers proven clinical and administrative solutions that improve whole-person health while making health care simpler and more affordable. Its solutions encompass total cost of care management, specialty care ...

Highlights
Evolent Health's net income has increased by 45% YoY and by 23% QoQ
The EPS rose by 37% YoY and by 12% QoQ
The gross margin has contracted by 38% YoY and by 10% from the previous quarter
EVH's gross profit is down by 20% year-on-year and by 7% since the previous quarter

Key stats

What are the main financial stats of EVH
Market
Shares outstanding
116.59M
Market cap
$1.26B
Enterprise value
$1.87B
Valuations
Price to earnings (P/E)
N/A
Price to book (P/B)
1.25
Price to sales (P/S)
0.48
EV/EBIT
N/A
EV/EBITDA
23.31
EV/Sales
0.73
Earnings
Revenue
$2.55B
Gross profit
$367.35M
Operating income
-$35.58M
Net income
-$61.62M
EBIT
-$38.31M
EBITDA
$80.06M
Free cash flow
-$6.13M
Per share
EPS
-$0.81
EPS diluted
-$0.81
Free cash flow per share
-$0.05
Book value per share
$8.59
Revenue per share
$22.28
TBVPS
$6.34
Balance sheet
Total assets
$2.54B
Total liabilities
$1.35B
Debt
$713.67M
Equity
$1B
Working capital
-$108.38M
Liquidity
Debt to equity
0.71
Current ratio
0.85
Quick ratio
0.81
Net debt/EBITDA
7.61
Margins
EBITDA margin
3.1%
Gross margin
14.4%
Net margin
-2.4%
Operating margin
-1.4%
Efficiency
Return on assets
-3.7%
Return on equity
-8.6%
Return on invested capital
-5.9%
Return on capital employed
-2.1%
Return on sales
-1.5%
Dividend
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A

EVH stock price

How has the Evolent Health stock price performed over time
Intraday
3.16%
1 week
8.34%
1 month
12.88%
1 year
-60.47%
YTD
-4.18%
QTD
13.83%

Financial performance

How have Evolent Health's revenue and profit performed over time
Revenue
$2.55B
Gross profit
$367.35M
Operating income
-$35.58M
Net income
-$61.62M
Gross margin
14.4%
Net margin
-2.4%
The net margin has soared by 59% YoY and by 27% QoQ
The operating margin has increased by 48% YoY but it has decreased by 27% from the previous quarter
Evolent Health's net income has increased by 45% YoY and by 23% QoQ
The gross margin has contracted by 38% YoY and by 10% from the previous quarter

Price vs fundamentals

How does EVH's price correlate with its fundamentals

Growth

What is Evolent Health's growth rate over time

Valuation

What is Evolent Health stock price valuation
P/E
N/A
P/B
1.25
P/S
0.48
EV/EBIT
N/A
EV/EBITDA
23.31
EV/Sales
0.73
The EPS rose by 37% YoY and by 12% QoQ
EVH's price to book (P/B) is 58% lower than its 5-year quarterly average of 3.0 and 48% lower than its last 4 quarters average of 2.4
The company's equity fell by 6% YoY and by 3.6% QoQ
The price to sales (P/S) is 75% lower than the 5-year quarterly average of 1.9 and 56% lower than the last 4 quarters average of 1.1
The revenue has grown by 30% YoY and by 3.7% from the previous quarter

Efficiency

How efficient is Evolent Health business performance
The ROS has soared by 80% YoY and by 42% QoQ
EVH's return on invested capital has surged by 73% year-on-year and by 41% since the previous quarter
The ROE has grown by 34% YoY and by 9% from the previous quarter
Evolent Health's return on assets has increased by 31% YoY and by 8% QoQ

Dividends

What is EVH's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for EVH.

Financial health

How did Evolent Health financials performed over time
The company's total assets is 88% higher than its total liabilities
The quick ratio has contracted by 18% from the previous quarter and by 16% YoY
The company's current ratio fell by 18% QoQ and by 16% YoY
The debt is 29% lower than the equity
EVH's debt to equity is up by 18% year-on-year and by 16% since the previous quarter
The debt has increased by 12% QoQ and by 11% YoY

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.